Literature DB >> 9538200

L-kynurenine 3-monooxygenase from mitochondrial outer membrane of pig liver: purification, some properties, and monoclonal antibodies directed to the enzyme.

T Uemura1, K Hirai.   

Abstract

We have purified L-kynurenine 3-monooxygenase from pig liver mitochondria using a procedure involving seven steps composed of (1) preparation of mitochondrial outer membrane, (2) preparation of the zwitterionic detergent, 3-[(3-cholamidopropyl)dimethylammonio]-1-propane sulfonate (Chaps) insoluble outer membrane material, (3) extraction of the enzyme with beta-octylglucoside, (4) ammonium sulfate fractionation, (5) DEAE-Sepharose CL-6B chromatography, (6) Matrex gel orange A affinity chromatography, and (7) high-performance liquid chromatography (HPLC) gel filtration. The final preparation had an about 160-fold purified enzyme activity with a yield of 0.8%. The apparent molecular mass of the aggregated form of the native enzyme was determined to be close to 300 kDa by HPLC gel filtration in the presence of 0.005% Triton X-100. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) showed a main protein band with an apparent molecular mass of about 49 kDa. The enzyme was found to be about 86% pure by the criterion of SDS-PAGE. The dissociated form of the enzyme contains 1 mol of non-covalently bound FAD/mol of protein monomer. The UV/visible spectrum had absorption peaks at 275, 384, and 450 nm, typical of a simple flavoprotein. Five inhibitory monoclonal antibodies against the enzyme were obtained. They could stain moderately a single protein band (49 kDa) in a Western blot.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9538200     DOI: 10.1093/oxfordjournals.jbchem.a021930

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  6 in total

Review 1.  Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.

Authors:  Robert Schwarcz; Paolo Guidetti; Korrapati V Sathyasaikumar; Paul J Muchowski
Journal:  Prog Neurobiol       Date:  2009-04-24       Impact factor: 11.685

Review 2.  The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative disease.

Authors:  Marta Amaral; Tiago F Outeiro; Nigel S Scrutton; Flaviano Giorgini
Journal:  J Mol Med (Berl)       Date:  2013-05-01       Impact factor: 4.599

Review 3.  Advantages of brain penetrating inhibitors of kynurenine-3-monooxygenase for treatment of neurodegenerative diseases.

Authors:  Shaowei Zhang; Mary E W Collier; Derren J Heyes; Flaviano Giorgini; Nigel S Scrutton
Journal:  Arch Biochem Biophys       Date:  2020-12-01       Impact factor: 4.013

4.  Method for Evaluation of the Requirements of B-group Vitamins Using Tryptophan Metabolites in Human Urine.

Authors:  Katsumi Shibata; Junko Hirose; Tsutomu Fukuwatari
Journal:  Int J Tryptophan Res       Date:  2015-04-19

5.  Bacterial expression of human kynurenine 3-monooxygenase: solubility, activity, purification.

Authors:  K Wilson; D J Mole; M Binnie; N Z M Homer; X Zheng; B A Yard; J P Iredale; M Auer; S P Webster
Journal:  Protein Expr Purif       Date:  2013-12-04       Impact factor: 1.650

6.  Structural basis of kynurenine 3-monooxygenase inhibition.

Authors:  Marta Amaral; Colin Levy; Derren J Heyes; Pierre Lafite; Tiago F Outeiro; Flaviano Giorgini; David Leys; Nigel S Scrutton
Journal:  Nature       Date:  2013-04-10       Impact factor: 49.962

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.